Want to see NPCE full AI Analyst Report?
Total Valuation
NeuroPace has a market cap or net worth of $513.11M. The enterprise value is $560.15.
Market Cap$513.11M
Enterprise Value$560.15
Share Statistics
NeuroPace has 34,093,746 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,093,746
Owned by Insiders16.75%
Owned by Institutions9.77%
Financial Efficiency
NeuroPace’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -18.18%.
Return on Equity (ROE)-1.13
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-18.18%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee454.48K
Profits Per Employee-97.57K
Employee Count220
Asset Turnover0.95
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of NeuroPace is ―. NeuroPace’s PEG ratio is 0.81.
PE Ratio―
PS Ratio5.05
PB Ratio26.55
Price to Fair Value26.55
Price to FCF-44.56
Price to Operating Cash Flow-44.17
PEG Ratio0.81
Income Statement
In the last 12 months, NeuroPace had revenue of 99.99M and earned -21.46M in profits. Earnings per share was -0.66.
Revenue99.99M
Gross Profit77.22M
Operating Income-16.34M
Pretax Income-21.46M
Net Income-21.46M
EBITDA-12.06M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was -11.24M and capital expenditures -127.00K, giving a free cash flow of -11.37M billion.
Operating Cash Flow-11.24M
Free Cash Flow-11.37M
Free Cash Flow per Share-0.33
Dividends & Yields
NeuroPace pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change56.22%
50-Day Moving Average15.55
200-Day Moving Average15.24
Relative Strength Index (RSI)46.81
Average Volume (3m)181.28K
Important Dates
NeuroPace upcoming earnings date is Nov 10, 2026, After Close (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
NeuroPace as a current ratio of 5.28, with Debt / Equity ratio of 588.50%
Current Ratio5.28
Quick Ratio4.33
Debt to Market Cap0.12
Net Debt to EBITDA-4.08
Interest Coverage Ratio-2.19
Taxes
In the past 12 months, NeuroPace has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NeuroPace EV to EBITDA ratio is -45.97, with an EV/FCF ratio of -48.90.
EV to Sales5.54
EV to EBITDA-45.97
EV to Free Cash Flow-48.90
EV to Operating Cash Flow-50.37
Balance Sheet
NeuroPace has $51.70M in cash and marketable securities with $69.93M in debt, giving a net cash position of -$18.23M billion.
Cash & Marketable Securities$51.70M
Total Debt$69.93M
Net Cash-$18.23M
Net Cash Per Share-$0.53
Tangible Book Value Per Share$0.58
Margins
Gross margin is 79.63%, with operating margin of -16.34%, and net profit margin of -21.47%.
Gross Margin79.63%
Operating Margin-16.34%
Pretax Margin-21.47%
Net Profit Margin-21.47%
EBITDA Margin-12.06%
EBIT Margin-14.01%
Analyst Forecast
The average price target for NeuroPace is $20.40, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$20.40
Price Target Upside37.74% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast11.59%
EPS Growth Forecast31.90%